| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 12, 2021 | May 13, 2021 | Oruka Therapeutics, Inc. | Director | Buy | 91.3 | +10,000 | 25.00% | ✗ | $31.9K |
| May 5, 2021 | May 6, 2021 | Oruka Therapeutics, Inc. | Director | Buy | 91.3 | +10,000 | 33.33% | ✗ | $32.3K |
| Dec 18, 2020 | Dec 21, 2020 | Oruka Therapeutics, Inc. | Director | Buy | 91.3 | +10,000 | 50.00% | ✗ | $41.6K |
| Sep 25, 2020 | Sep 25, 2020 | Oruka Therapeutics, Inc. | Director | Buy | 91.3 | +5,000 | 33.33% | ✗ | $21.4K |
| Sep 22, 2020 | Sep 24, 2020 | Oruka Therapeutics, Inc. | Director | Buy | 91.3 | +3,056 | 25.59% | ✗ | $14.2K |
| Sep 21, 2020 | Sep 21, 2020 | Oruka Therapeutics, Inc. | Director | Buy | 91.3 | +10,000 | 514.40% | ✗ | $47.7K |
| Jul 14, 2017 | Jul 17, 2017 | Oruka Therapeutics, Inc. | Director | Buy | 91.3 | +10,000 | 40.00% | ✗ | $24.9K |
| Mar 24, 2017 | Mar 27, 2017 | Oruka Therapeutics, Inc. | Director | Buy | 95.0 | +25,000 | 100.00% | ✗ | $64.8K |